As filed with the Securities and Exchange Commission on March 29, 2019

Registration No.    

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM S-8

 

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

 


 

EGALET CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware

 

600 Lee Road, Suite 100
Wayne, PA 19087

 

46-3575334

(State of Incorporation)

 

(Address of principal executive offices)
(Zip Code)

 

(I.R.S. Employer
Identification No.)

 

EGALET CORPORATION

AMENDED AND RESTATED 2019 STOCK-BASED INCENTIVE COMPENSATION PLAN

(Full Title of the Plan)

 

Robert S. Radie
President and Chief Executive Officer

Egalet Corporation

600 Lee Road

Suite 100

Wayne, PA 19087

(Name and Address of Agent for Service)

 

(610) 833-4200

(Telephone Number, Including Area Code, of Agent for Service)

 

With a Copy to:

 

David S. Rosenthal, Esq.

Dechert LLP

1095 Avenue of the Americas

New York, New York 10036

(212) 698-3500

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o

Accelerated filer o

Non-accelerated filer o

Smaller reporting company x

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. x

 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

 

Title Of
Securities
To Be
Registered

 

Amount
To Be
Registered (1)

 

Proposed
Maximum
Offering
Price Per Share
(2)

 

Proposed
Maximum
Aggregate
Offering Price
(2)

 

Amount Of
Registration
Fee

 

Common Stock, par value $0.001 per share

 

2,150,000

 

$

3.05

 

$

6,557,500.00

 

$

794.77

 

(1)                                  This Registration Statement relates to 2,150,000 shares of common stock of Egalet Corporation (the “Registrant”) not previously registered and available for issuance under the Registrant’s Amended and Restated 2019 Stock-Based Incentive Compensation Plan (the “Plan”). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s common stock which become issuable under the Plan pursuant to this registration statement by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of common stock.

 

(2)                                  The Proposed Maximum Offering Price Per Share and Proposed Maximum Aggregate Offering Price have been calculated solely for purposes of determining the applicable registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the bid and ask per share of common stock of the Registrant on March 26, 2019, as reported on the Over the Counter Market.

 

 

 


 

PART I

 

INFORMATION REQUIRED IN SECTION 10(a) PROSPECTUS

 

Information required in Part I of Form S-8 to be contained in a prospectus meeting the requirements of Section 10(a) of the Securities Act of 1933, as amended (the “Securities Act”), is not required to be filed with the Securities and Exchange Commission (the “Commission”) and is omitted from this Registration Statement in accordance with this explanatory note to Part I of Form S-8 and Rule 428 under the Securities Act.  The documents containing the information specified in Part I of Form S-8 will be sent or given to directors, officers, employees and consultants as specified by Rule 428(b)(1) of the Securities Act.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3.                                                          Incorporation of Documents by Reference.

 

The following documents, as originally filed with the Commission by Egalet Corporation (the “Registrant”) are hereby incorporated herein by reference:

 

(a)                                  The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed on March 29, 2019.

 

(b)                                  The Registrant’s current reports on Form 8-K filed on January 16, 2019, February 1, 2019 and March 20, 2019.

 

(c)                                   All other reports filed by the Registrant pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since December 31, 2018.

 

(d)                                  The description of the Registrant’s common stock, par value $0.001 per share, contained in its registration statement on Form 8-A, which was filed with the Commission on February 3, 2014, including any amendment or report filed for the purpose of updating such description.

 

All reports and other documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date of this Registration Statement, but prior to the filing of a post-effective amendment to this Registration Statement, which indicates that all securities offered by this Registration Statement have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement.  Each document incorporated by reference into this Registration Statement shall be deemed to be a part of this Registration Statement from the date of the filing of such document with the Commission until the information contained therein is superseded or updated by any subsequently filed document which is incorporated by reference into this Registration Statement.

 

Item 4.                                                          Description of Securities.

 

Not applicable.

 

Item 5.                                                          Interests of Named Experts and Counsel .

 

Not applicable.

 

Item 6.                                                          Indemnification of Directors and Officers.

 

The Registrant is incorporated under the laws of the State of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons who are, or are

 

2


 

threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. A Delaware corporation may indemnify any persons who are, or are threatened to be made, a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person was a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses which such officer or director has actually and reasonably incurred. The Registrant’s certificate of incorporation and bylaws provide for the indemnification of its directors and officers to the fullest extent permitted under the Delaware General Corporation Law.

 

Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any:

 

·                                           transaction from which the director derives an improper personal benefit;

 

·                                           act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

 

·                                           unlawful payment of dividends or redemption of shares; or

 

·                                           breach of a director’s duty of loyalty to the corporation or its stockholders.

 

The Registrant’s certificate of incorporation includes such a provision. Expenses incurred by any officer or director in defending any such action, suit or proceeding in advance of its final disposition shall be paid by the Registrant upon delivery to the Registrant of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified by the Registrant.

 

As permitted by the Delaware General Corporation Law, the Registrant has entered into indemnity agreements with each of its directors and executive officers. These agreements, among other things, require the Registrant to indemnify each director and officer to the fullest extent permitted by law and advance expenses to each indemnitee in connection with any proceeding in which indemnification is available.

 

The Registrant maintains an insurance policy covering its officers and directors with respect to certain liabilities, including liabilities arising under the Securities Act or otherwise.

 

Item 7.                                                          Exemption from Registration Claimed.

 

Not applicable.

 

3


 

Item 8.                                                          Exhibits.

 

Exhibit No.

 

Description

4.1

 

Fourth Amended and Restated Certificate of Incorporation of Egalet Corporation, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 1, 2019).

 

 

 

4.2

 

Second Amended and Restated Bylaws of Egalet Corporation (incorporated by reference to Exhibit 3.2 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.3

 

Form of Certificate of Common Stock (incorporated by reference to Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K filed with the Commission on March 29, 2019).

 

 

 

4.4

 

Indenture, dated as of January 31, 2019, among Egalet Corporation, the Guarantors from time to time party thereto and U.S. Bank National Association, as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.5

 

Form of Iroko Warrant Agreement (incorporated by reference to Exhibit 4.3 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.6

 

Form of Non-Iroko Warrant Agreement (incorporated by reference to Exhibit 4.4 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.7

 

Form of Preemptive Rights Agreement (incorporated by reference to Exhibit 10.4 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.8

 

Registration Rights Agreement, dated as of January 31, 2019, by and between the Company and Iroko Pharmaceuticals Inc. (incorporated by reference to Exhibit 10.7 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.9

 

Stockholders’ Agreement, dated as of January 31, 2019, by and among Egalet Corporation and the stockholder(s) of Egalet Corporation from time to time party thereto (incorporated by reference to Exhibit 10.3 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.10

 

Egalet Corporation Form of Time-Based Restricted Stock Unit Agreement (filed herewith).

 

 

 

4.11

 

Egalet Corporation Form of Performance Restricted Stock Unit Agreement (filed herewith).

 

 

 

5.1

 

Opinion of Dechert LLP (counsel to the Registrant) as to the legality of the securities being registered (filed herewith).

 

 

 

10.1

 

Amended and Restated Egalet Corporation 2019 Stock-Based Incentive Compensation Plan, as amended (filed herewith).

 

 

 

23.1

 

Consent of Ernst & Young LLP (filed herewith).

 

 

 

23.2

 

Consent of Dechert LLP (included in Exhibit 5.1 filed herewith).

 

 

 

24.1

 

Power of Attorney (included on the signature pages hereto).

 

4


 

Item 9.  Undertakings.

 

(a)                                  The undersigned Registrant hereby undertakes:

 

(1)                                  To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement to include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

 

(2)                              That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial  bona fide  offering thereof.

 

(3)                                  To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(b)                                  The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial  bona fide  offering thereof.

 

(c)                                   Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

5


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

4.1

 

Fourth Amended and Restated Certificate of Incorporation of Egalet Corporation, as amended (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 1, 2019).

 

 

 

4.2

 

Second Amended and Restated Bylaws of Egalet Corporation (incorporated by reference to Exhibit 3.2 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.3

 

Form of Certificate of Common Stock (incorporated by reference to Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K filed with the Commission on March 29, 2019).

 

 

 

4.4

 

Indenture, dated as of January 31, 2019, among the Company, the Guarantors from time to time party thereto and U.S. Bank National Association, as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.5

 

Form of Iroko Warrant Agreement (incorporated by reference to Exhibit 4.3 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.6

 

Form of Non-Iroko Warrant Agreement (incorporated by reference to Exhibit 4.4 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.7

 

Form of Preemptive Rights Agreement (incorporated by reference to Exhibit 10.4 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.8

 

Registration Rights Agreement, dated as of January 31, 2019, by and between the Company and Iroko Pharmaceuticals Inc. (incorporated by reference to Exhibit 10.7 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.9

 

Stockholders’ Agreement, dated as of January 31, 2019, by and among the Company and the stockholder(s) of the Copany from time to time party thereto (incorporated by reference to Exhibit 10.3 to the Registrant’s current report on Form 8-K filed with the Commission on February 1, 2019).

 

 

 

4.10

 

Egalet Corporation Form of Time Based Restricted Stock Unit Agreement (filed herewith).

 

 

 

4.11

 

Egalet Corporation Form of Performance Restricted Stock Unit Agreement (filed herewith).

 

 

 

5.1

 

Opinion of Dechert LLP (counsel to the Registrant) as to the legality of the securities being registered (filed herewith).

 

 

 

10.1

 

Amended and Restated Egalet Corporation 2019 Stock-Based Incentive Compensation Plan, as amended (filed herewith).

 

 

 

23.1

 

Consent of Ernst & Young LLP (filed herewith).

 

 

 

23.2

 

Consent of Dechert LLP (included in Exhibit 5.1 filed herewith).

 

 

 

24.1

 

Power of Attorney (included on the signature pages hereto).

 

6


 

SIGNATURES

 

The Registrant.  t. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Wayne, Commonwealth of Pennsylvania, on this 29th day of March, 2019.

 

 

EGALET CORPORATION

 

 

 

 

By:

/s/ ROBERT RADIE

 

 

Robert Radie

 

 

President and Chief Executive Officer

 

7


 

POWER OF ATTORNEY

 

KNOW TO ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert S. Radie, Mark Strobeck and Megan Timmins, each and individually, his or her attorneys-in-fact, with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any or all amendments or post-effective amendments to this Registration Statement and to file the same with the Securities and Exchange Commission, granting unto each of such attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that each such attorney-in-fact, or his agent or substitutes, may do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act, this Form S-8 have been signed by the following persons in the capacities indicated on the dates indicated.

 

SIGNATURE

 

TITLE

 

DATE

 

 

 

 

 

/s/ ROBERT RADIE

 

President, Chief Executive Officer and Director

 

March 29, 2019

Robert Radie

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ BARBARA CARLIN

 

Chief Accounting Officer
(Principal Accounting Officer and Principal Financial Officer)

 

March 29, 2019

Barbara Carlin

 

 

 

 

 

 

 

 

 

/s/ TIMOTHY WALBERT

 

Chairman of the Board

 

March 29, 2019

Timothy Walbert

 

 

 

 

 

 

 

 

 

/s/ LUKE DÜSTER

 

Director

 

March 29, 2019

Luke Düster

 

 

 

 

 

 

 

 

 

/s/ TODD HOLMES

 

Director

 

March 29, 2019

Todd Holmes

 

 

 

 

 

 

 

 

 

/s/ JOE MCINNIS

 

Director

 

March 29, 2019

Joe McInnis

 

 

 

 

 

 

 

 

 

/s/ MATTHEW PAULS

 

Director

 

March 29, 2019

Matthew Pauls

 

 

 

 

 

 

 

 

 

/s/ ANDREA HESLIN SMILEY

 

Director

 

March 29, 2019

Andrea Heslin Smiley

 

 

 

 

 

8


Exhibit 4.10

 

EGALET CORPORATION

Time-Based Restricted Stock Unit Award Agreement

 

This Restricted Stock Unit Award Agreement (this “ Agreement ”) is made and entered into as of             , 2019 (the “ Grant Date ”) by and between Egalet Corporation, a Delaware corporation (the “ Company ”) and [        ] (the “ Grantee ”).

 

WHEREAS , the Company has adopted the Egalet Corporation Amended and Restated 2019 Stock-Based Incentive Compensation Plan, as amended and/or restated from time to time (the “ Plan ”), pursuant to which awards of Restricted Stock Units may be granted; and

 

WHEREAS , the Committee has determined that it is in the best interests of the Company and its stockholders to grant the award of Restricted Stock Units provided for herein.

 

NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows:

 

1.               Grant of Restricted Stock Units . Pursuant to the terms of the Plan, the Company hereby grants to the Grantee on the Grant Date an award of Restricted Stock Units (the “ RSUs ”) representing a contingent right to receive up to the number of shares of Common Stock set forth in the Notice of Grant attached hereto as Exhibit A (the “ Grant Notice ”), on the terms and conditions and subject to the restrictions set forth in this Agreement, the Grant Notice and the Plan. Capitalized terms that are used but not defined herein have the meaning ascribed to them in the Plan.

 

2.               Restriction Period; Vesting .  The RSUs shall be eligible to vest in accordance with the vesting schedule set forth in the Grant Notice.

 

3.               Termination .  If the Grantee’s service with the Company, a Subsidiary or an Affiliate of the Company terminates for any reason (regardless of whether such termination is initiated by the Grantee, by the Company, by any Subsidiary or by any Company Affiliate) at any time before all of his or her RSUs have vested, the Grantee’s unvested RSUs shall be automatically forfeited upon such termination of service without any payment or compensation due to the Grantee, and neither the Company nor any Subsidiary or Company Affiliate shall have any further obligations to the Grantee under this Agreement.

 

4.               Settlement .  The Grantee shall be entitled to receive one share of Common Stock for each RSU that becomes vested as soon as practicable (and in any event within 60 days) after the applicable vesting date.

 

5.               Restrictions .  The Grantee shall have no rights with respect to the shares of Common Stock underlying the RSUs until those shares of Common Stock are delivered to the Grantee in settlement thereof, and neither the RSUs nor any rights relating thereto may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee (other

 


 

than transfers upon the death of the Grantee pursuant to will or the laws of descent and distribution). Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the RSUs or the rights relating thereto (other than transfers upon the death of the Grantee pursuant to will or the laws of descent and distribution) shall be wholly ineffective and, if any such attempt is made, the RSUs and all rights relating thereto will be forfeited by the Grantee and all of the Grantee’s rights to shares of Common Stock underlying the RSUs shall immediately terminate without any payment or compensation by the Company or any Subsidiary or Company Affiliate.

 

6.               No Stockholder Rights; Dividend Equivalent Rights .  Prior to the delivery of shares of Common Stock upon the settlement of the RSUs, the Grantee shall have no rights as a stockholder with respect to such shares of Common Stock (including, without limitation, the right to vote).  Notwithstanding the foregoing or anything herein to the contrary, if the Company declares a cash dividend on the Common Stock during the period between the Grant Date and the date on which shares of Common Stock are delivered upon the settlement of any vested RSUs, the Grantee shall be entitled to receive an amount in cash equal to the product of (i) the number of RSUs then outstanding, multiplied by (ii) the amount of the cash dividend per share of Common Stock then declared, as if the Grantee had held a number of shares of Common Stock equal to the number of RSUs outstanding as of each dividend record date during such period, with such cash payment to be made to the Grantee at the same time as shares of Common Stock are issued upon the settlement of such RSUs (if the underlying RSUs are forfeited, then the dividend equivalents attributable to such RSUs also shall be forfeited with no compensation or other payment due to the Grantee or any other person or entity).

 

7.               No Right to Continued Service . Neither the Plan nor this Agreement or the Grant Notice shall confer upon the Grantee any right to be retained in any position, as an Employee, Consultant or Non-Employee Director of the Company or any Subsidiary or Company Affiliate.  Further, nothing in the Plan, this Agreement or the Grant Notice shall be construed to limit the discretion of the Company or any Subsidiary or Company Affiliate to terminate the Grantee’s employment or other service at any time, for any reason, with or without cause and with or without notice.

 

8.               Adjustments . The RSUs and the number and type of securities underlying the RSUs shall be subject to adjustment in the manner provided under Section 12 of the Plan.

 

9.               Tax Liability and Withholding .  The Grantee shall be required to pay to the Company or any applicable Subsidiary and Company Affiliate, and the Company, the Subsidiaries and the Company Affiliates shall have the right to deduct from any compensation paid to the Grantee pursuant to the Plan or otherwise, the amount of any required withholding taxes in respect of the RSUs and/or the shares of Common Stock underlying the RSUs and to take all such other actions as the Committee deems necessary to satisfy all obligations for the payment of such withholding taxes.  The Grantee may satisfy any federal, state or local tax withholding obligation by any of the following means, or by a combination of such means:

 

(a)                 tendering a cash payment;

 

2


 

(b)                 tendering proceeds received from a broker-dealer authorized by the Grantee to sell all or a portion of the shares of Common Stock delivered to the Grantee as a result of the settlement of the RSUs; or

 

(c)                  delivering to the Company previously owned and unencumbered shares of Common Stock.

 

10.        Compliance with Law . The issuance and transfer of Common Stock (and payment of dividend equivalents) shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Common Stock may be listed. No Common Stock shall be issued or transferred (and no dividend equivalents shall be paid) unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. The Grantee understands that the Company is under no obligation to register the Common Stock with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.

 

11.        Stock Issuance . Upon the delivery of shares of Common Stock to the Grantee upon the settlement of the RSUs, the Company may issue stock certificates or evidence the Grantee’s interest by using a book entry account with the Company’s transfer agent.  A physical or electronic legend, as applicable, may be placed on any certificate(s) representing the shares of Common Stock issued pursuant to this Agreement indicating restrictions on transferability of such shares or any other restrictions that the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any applicable federal, state or other securities laws or any stock exchange on which shares of Common Stock are then listed or quoted.

 

12.        Governing Law . This Agreement will be construed and interpreted in accordance with the laws of the State of Delaware without regard to conflict of law principles.

 

13.        RSUs Subject to Plan . This Agreement is subject to the Plan. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.

 

14.        Section 409A . It is intended that the RSUs and this Agreement be exempt from Section 409A of the Code and, to the extent not so exempt, that the RSUs and this Agreement comply with the requirements of Section 409A of the Code, and this Agreement shall be interpreted consistently with the foregoing without resulting in any increase in the amounts owed hereunder by the Company or any Subsidiary or Company Affiliate.  Notwithstanding anything contained herein, in the Grant Notice or in the Plan to the contrary, neither the Company nor any Subsidiary or Company Affiliate shall have any liability or obligation to the Grantee or to any other person or

 

3


 

entity in the event that the RSUs and/or this Agreement are not exempt from, or compliant with, Section 409A of the Code.

 

15.        Successors and Assigns . The Company may assign any of its rights and obligations under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee and the Grantee’s beneficiaries, executors, administrators and the person(s) and entities to whom the RSUs may be transferred by will or the laws of descent or distribution.

 

16.        Amendment . The Committee has the right to amend, alter, suspend, discontinue or cancel the RSUs and all rights relating thereto, prospectively or retroactively; provided, that , no such action shall adversely affect the Grantee’s material rights under this Agreement without the Grantee’s consent.

 

17.        Recoupment . The RSUs and any compensation paid with respect thereto shall be subject to mandatory repayment by the Grantee to the Company pursuant to the terms of any Company “clawback” or recoupment policy applicable to the Plan as in effect from time to time or required by law to be applicable to the Grantee.

 

18.        Acceptance . The Grantee hereby acknowledges receipt of a copy of the Plan and this Agreement. The Grantee has read and understands the terms and provisions hereof and thereof, and accepts the RSUs subject to all of the terms and conditions of the Plan and this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

4


 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

 

EGALET CORPORATION

 

 

 

By:

 

 

Name:

 

Title:

 

 

GRANTEE

 

 

 

 

 

Name:

 


 

Exhibit A

 

Notice of Grant

 

This Notice of Grant sets forth the specific terms that apply to the Restricted Stock Units granted to the Grantee identified below under the Restricted Stock Unit Award Agreement (the “ Agreement ”), made and entered into as of            , 2019, between Egalet Corporation, a Delaware corporation (the “ Company ”), and the Grantee.  Capitalized terms that are used but not defined herein shall have the meanings given to such terms in the Agreement.

 

Grantee Name :

[                   ]

 

 

 

 

Number of Shares of Common Stock

 

Covered by the RSUs :

[                   ]

 

 

 

 

Grant Date :

[                   ]

 

 

Vesting Schedule :                                              [Subject to the Grantee’s continuing employment with the Company or any Subsidiary or Company Affiliate on the applicable vesting date, 1/3 of the RSUs shall vest, and the restrictions applicable thereto shall lapse, on each of the first three anniversaries of the Grant Date.  The unvested portion of the RSUs will be forfeited immediately for no compensation or other payment upon the Grantee’s termination of employment for any reason (and regardless of who initiates such termination).]

 

[Subject to the Grantee’s continuing employment with the Company or any Subsidiary or Company Affiliate on the applicable vesting date, 100% of the RSUs shall vest, and the restrictions applicable thereto shall lapse, on the first anniversary of the Grant Date.  The unvested portion of the RSUs will be forfeited immediately for no compensation or other payment upon the Grantee’s termination of employment for any reason (and regardless of who initiates such termination).]

 

Notwithstanding the foregoing, if the Grantee remains in continuous employment with the Company or any Subsidiary until the date of a Change in Control that satisfies the requirements of Treasury Regulation 1.409A-3(i)(5), 100% of the unvested RSUs shall vest and be settled upon or immediately prior to the consummation of such Change in Control.

 


Exhibit 4.11

 

EGALET CORPORATION

Performance Restricted Stock Unit Award Agreement

 

This Restricted Stock Unit Award Agreement (this “ Agreement ”) is made and entered into as of            , 2019 (the “ Grant Date ”) by and between Egalet Corporation, a Delaware corporation (the “ Company ”) and [        ] (the “ Grantee ”).

 

WHEREAS , the Company has adopted the Egalet Corporation Amended and Restated 2019 Stock-Based Incentive Compensation Plan, as amended and/or restated from time to time (the “ Plan ”), pursuant to which awards of Restricted Stock Units may be granted; and

 

WHEREAS , the Committee has determined that it is in the best interests of the Company and its stockholders to grant the award of Restricted Stock Units provided for herein.

 

NOW, THEREFORE, the parties hereto, intending to be legally bound, agree as follows:

 

1.               Grant of Restricted Stock Units . Pursuant to the terms of the Plan, the Company hereby grants to the Grantee on the Grant Date an award of Restricted Stock Units (the “ RSUs ”) representing a contingent right to receive up to the number of shares of Common Stock set forth in the Notice of Grant attached hereto as Exhibit A (the “ Grant Notice ”), on the terms and conditions and subject to the restrictions set forth in this Agreement, the Grant Notice and the Plan. Capitalized terms that are used but not defined herein have the meaning ascribed to them in the Plan.

 

2.               Restriction Period; Vesting .  The RSUs shall be eligible to vest in accordance with the vesting schedule set forth in the Grant Notice.

 

3.               Termination .  If the Grantee’s service with the Company, a Subsidiary or a Company Affiliate terminates for any reason (regardless of whether such termination is initiated by the Grantee, by the Company, by any Subsidiary or by any Company Affiliate) at any time before all of his or her RSUs have vested, the Grantee’s unvested RSUs shall be automatically forfeited upon such termination of service without any payment or compensation due to the Grantee, and neither the Company nor any Subsidiary or Company Affiliate shall have any further obligations to the Grantee under this Agreement.

 

4.               Settlement .  The Grantee shall be entitled to receive one share of Common Stock for each RSU that becomes vested as soon as practicable (and in any event within 60 days) after the applicable vesting date.

 

5.               Restrictions .  The Grantee shall have no rights with respect to the shares of Common Stock underlying the RSUs until those shares of Common Stock are delivered to the Grantee in settlement thereof, and neither the RSUs nor any rights relating thereto may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Grantee (other

 


 

than transfers upon the death of the Grantee pursuant to will or the laws of descent and distribution). Any attempt to assign, alienate, pledge, attach, sell or otherwise transfer or encumber the RSUs or the rights relating thereto (other than transfers upon the death of the Grantee pursuant to will or the laws of descent and distribution) shall be wholly ineffective and, if any such attempt is made, the RSUs and all rights relating thereto will be forfeited by the Grantee and all of the Grantee’s rights to shares of Common Stock underlying the RSUs shall immediately terminate without any payment or compensation by the Company or any Subsidiary or Company Affiliate.

 

6.               No Stockholder Rights; Dividend Equivalent Rights .  Prior to the delivery of shares of Common Stock upon the settlement of the RSUs, the Grantee shall have no rights as a stockholder with respect to such shares of Common Stock (including, without limitation, the right to vote).  Notwithstanding the foregoing or anything herein to the contrary, if the Company declares a cash dividend on the Common Stock during the period between the Grant Date and the date on which shares of Common Stock are delivered upon the settlement of any vested RSUs, the Grantee shall be entitled to receive an amount in cash equal to the product of (i) the number of RSUs then outstanding, multiplied by (ii) the amount of the cash dividend per share of Common Stock then declared, as if the Grantee had held a number of shares of Common Stock equal to the number of RSUs outstanding as of each dividend record date during such period, with such cash payment to be made to the Grantee at the same time as shares of Common Stock are issued upon the settlement of such RSUs (if the underlying RSUs are forfeited, then the dividend equivalents attributable to such RSUs also shall be forfeited with no compensation or other payment due to the Grantee or any other person or entity).

 

7.               No Right to Continued Service . Neither the Plan nor this Agreement or the Grant Notice shall confer upon the Grantee any right to be retained in any position, as an Employee, Consultant or Non-Employee Director of the Company or any Subsidiary or Company Affiliate.  Further, nothing in the Plan, this Agreement or the Grant Notice shall be construed to limit the discretion of the Company or any Subsidiary or Company Affiliate to terminate the Grantee’s employment or other service at any time, for any reason, with or without cause and with or without notice.

 

8.               Adjustments . The RSUs and the number and type of securities underlying the RSUs shall be subject to adjustment in the manner provided under Section 12 of the Plan.

 

9.               Tax Liability and Withholding .  The Grantee shall be required to pay to the Company or any applicable Subsidiary and Company Affiliate, and the Company, the Subsidiaries and the Company Affiliates shall have the right to deduct from any compensation paid to the Grantee pursuant to the Plan or otherwise, the amount of any required withholding taxes in respect of the RSUs and/or the shares of Common Stock underlying the RSUs and to take all such other actions as the Committee deems necessary to satisfy all obligations for the payment of such withholding taxes.  The Grantee may satisfy any federal, state or local tax withholding obligation by any of the following means, or by a combination of such means:

 

(a)                 tendering a cash payment;

 

2


 

(b)                 tendering proceeds received from a broker-dealer authorized by the Grantee to sell all or a portion of the shares of Common Stock delivered to the Grantee as a result of the settlement of the RSUs; or

 

(c)                  delivering to the Company previously owned and unencumbered shares of Common Stock.

 

10.        Compliance with Law . The issuance and transfer of Common Stock (and payment of dividend equivalents) shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal and state securities laws and with all applicable requirements of any stock exchange on which the Common Stock may be listed. No Common Stock shall be issued or transferred (and no dividend equivalents shall be paid) unless and until any then applicable requirements of state and federal laws and regulatory agencies have been fully complied with to the satisfaction of the Company and its counsel. The Grantee understands that the Company is under no obligation to register the Common Stock with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.

 

11.        Stock Issuance . Upon the delivery of shares of Common Stock to the Grantee upon the settlement of the RSUs, the Company may issue stock certificates or evidence the Grantee’s interest by using a book entry account with the Company’s transfer agent.  A physical or electronic legend, as applicable, may be placed on any certificate(s) representing the shares of Common Stock issued pursuant to this Agreement indicating restrictions on transferability of such shares or any other restrictions that the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any applicable federal, state or other securities laws or any stock exchange on which shares of Common Stock are then listed or quoted.

 

12.        Governing Law . This Agreement will be construed and interpreted in accordance with the laws of the State of Delaware without regard to conflict of law principles.

 

13.        RSUs Subject to Plan . This Agreement is subject to the Plan. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.

 

14.        Section 409A . It is intended that the RSUs and this Agreement be exempt from Section 409A of the Code and, to the extent not so exempt, that the RSUs and this Agreement comply with the requirements of Section 409A of the Code, and this Agreement shall be interpreted consistently with the foregoing without resulting in any increase in the amounts owed hereunder by the Company or any Subsidiary or Company Affiliate.  Notwithstanding anything contained herein, in the Grant Notice or in the Plan to the contrary, neither the Company nor any Subsidiary or Company Affiliate shall have any liability or obligation to the Grantee or to any other person or

 

3


 

entity in the event that the RSUs and/or this Agreement are not exempt from, or compliant with, Section 409A of the Code.

 

15.        Successors and Assigns . The Company may assign any of its rights and obligations under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee and the Grantee’s beneficiaries, executors, administrators and the person(s) and entities to whom the RSUs may be transferred by will or the laws of descent or distribution.

 

16.        Amendment . The Committee has the right to amend, alter, suspend, discontinue or cancel the RSUs and all rights relating thereto, prospectively or retroactively; provided, that , no such action shall adversely affect the Grantee’s material rights under this Agreement without the Grantee’s consent.

 

17.        Recoupment . The RSUs and any compensation paid with respect thereto shall be subject to mandatory repayment by the Grantee to the Company pursuant to the terms of any Company “clawback” or recoupment policy applicable to the Plan as in effect from time to time or required by law to be applicable to the Grantee.

 

18.        Acceptance . The Grantee hereby acknowledges receipt of a copy of the Plan and this Agreement. The Grantee has read and understands the terms and provisions hereof and thereof, and accepts the RSUs subject to all of the terms and conditions of the Plan and this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

4


 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

 

 

EGALET CORPORATION

 

 

 

By:

 

 

 

 

 

Name:

 

 

 

 

 

Title:

 

 

 

 

 

GRANTEE

 

 

 

 

 

 

 

 Name:

 

 


 

Exhibit A

 

Notice of Grant

 

This Notice of Grant sets forth the specific terms that apply to the Restricted Stock Units granted to the Grantee identified below under the Restricted Stock Unit Award Agreement (the “ Agreement ”), made and entered into as of            , 2019, between Egalet Corporation, a Delaware corporation (the “ Company ”), and the Grantee.  Capitalized terms that are used but not defined herein shall have the meanings given to such terms in the Agreement.

 

Grantee Name :

[           ]

 

 

Number of Shares of Common Stock

 

Covered by the RSUs :

[            ]

 

 

Grant Date :

[            ]

 

Vesting Schedule :                                              Subject to the Grantee’s continuing employment with the Company or any Subsidiary or Company Affiliate on the applicable vesting date, if 75% or greater of the corporate performance targets set forth below (the “ 2019 Corporate Goals ”) are attained on or prior to the first anniversary of the Grant Date, as determined by the Company’s Board of Directors in its sole discretion, then [a number of RSUs equal to the product of (x) the number of RSUs granted under the Agreement and (y) the Applicable Percentage (as defined below) shall vest, and the restrictions applicable thereto shall lapse, on March 1, 2020] [a number of RSUs equal to the product of (x) 50%, (y) the number of RSUs granted under the Agreement and (z) the Applicable Percentage (as defined below), shall vest, and the restrictions applicable thereto shall lapse, on each of March 1, 2020 and March 1, 2021].

 

The unvested portion of the RSUs will be forfeited immediately for no compensation or other payment upon the Grantee’s termination of employment for any reason (and regardless of who initiates such termination).  In the event that the Company’s Board of Directors determines in its sole discretion that less than 75% of the 2019 Corporate Goals were achieved, then upon such determination all of the RSUs shall be immediately forfeited (if not forfeited earlier) with no compensation or other payment due to the Grantee or any other person or entity.  In the event that the Company’s Board of Directors determines in its sole discretion that at least 75%, but less than 100%, of the 2019 Corporate Goals were achieved, then upon such determination a number of RSUs equal to the product of (x) the number of RSUs granted under the Agreement and (y) 100% minus the Applicable Percentage, shall be immediately forfeited (if not forfeited earlier) with no compensation or other payment due to the Grantee or any other person or entity.

 


 

Notwithstanding the foregoing, any RSUs that are outstanding and unvested immediately prior to the occurrence of a Change in Control shall vest and be settled upon or immediately prior to the consummation of such Change in Control.

 

2019 Corporate Goals :  [                    ]

 

Applicable Percentage:  For purposes of this Exhibit A, the “Applicable Percentage” shall be determined as follows:

 

Percentage of 2019 
Corporate Goals Achieved:

 

Applicable Percentage:

 

Less than 75%

 

0

%

75%

 

75

%

100% or more

 

100

%

 

In the event that the percentage of the 2019 Corporate Goals determined by the Company’s Board of Directors in its sole discretion to have been achieved is more than 75% but less than 100%, then the Applicable Percentage shall be determined on a straight-line basis.  For example, if 85% of the 2019 Corporate Goals were determined by the Company’s Board of Directors in its sole discretion to have been achieved, then the Applicable Percentage would be 85%.

 

2


Exhibit 5.1

 

Three Bryant Park

New York, NY 10036-6797

+1 212 698 3500 Main

+1 212 698 3599 Fax

www.dechert.com

 

March 29, 2019

 

Egalet Corporation
600 Lee Road., Suite 100
Wayne, PA 19087

 

Re:           REGISTRATION STATEMENT ON FORM S-8

 

Ladies and Gentlemen:

 

We have acted as counsel to Egalet Corporation, a Delaware corporation (the “ Company ”), in connection with the filing with the Securities and Exchange Commission (the “ Commission ”) of a Registration Statement on Form S-8 (the “ Registration Statement ”) for the purpose of registering under the Securities Act of 1933, as amended (the “ Securities Act ”), 2,150,000 shares of its common stock, par value $0.001 per share (the “ Shares ”), issuable under the Amended and Restated Egalet Corporation 2019 Stock-Based Incentive Compensation Plan (the “ Plan ”).  This opinion is being furnished to the Company in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement other than as expressly stated herein with respect to the Shares.

 

In connection with this opinion, we have examined original or copies (in each case, signed, certified or otherwise proven to our satisfaction to be genuine) of: (i) the Plan, (ii) the Company’s Fourth Amended and Restated Certificate of Incorporation (the “ Charter ”), (iii) the Second Amended and Restated Bylaws of the Company and (iv) resolutions approving the corporate action of the Company authorizing the issuances of the Shares.

 

In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as original documents, and the conformity to original documents of all documents submitted to us as copies, the legal capacity of natural persons who are signatories to the documents examined by us and the legal power and authority of all persons signing on behalf of parties (other than the Company) to all documents.

 

In rendering the opinion expressed below, we have assumed that prior to the issuance of any of the Shares, there will exist under the Charter the requisite number of authorized but unissued shares of common stock. In addition, we have assumed (i) the resolutions authorizing the Company to issue the Shares in accordance with the terms and conditions of the Plans will remain in effect and unchanged at all times during which the Shares are issued by the Company, and (ii) the Registration Statement, and any amendments thereto, at the time of issuance of the Shares, will continue to be effective under the Securities Act.

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the holder(s) and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the Plan, assuming in each case that the individual issuances, grants or awards under the Plan are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law and the Plan (and, in each case, the agreements and awards duly adopted thereunder and in accordance therewith), the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and non-assessable.

 

We are members of the Bar of the State of New York and the foregoing opinion is limited to the General Corporation Law of the State of Delaware.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

Very truly yours,

 

 

 /s/ Dechert LLP

 


EXHIBIT 10.1

 

 

EGALET CORPORATION

 

AMENDED AND RESTATED

2019 STOCK-BASED
INCENTIVE COMPENSATION PLAN

(Amended and Restated effective March 26, 2019)

 

1.                                       Purpose of the Plan

 

The purpose of the Plan is to assist the Company, its Subsidiaries and Company Affiliates in attracting and retaining valued Employees, Consultants and Non-Employee Directors by offering them a greater stake in the Company’s success and a closer identity with it, and to encourage ownership of the Company’s stock by such Employees, Consultants and Non-Employee Directors.

 

2.                                       Definitions

 

As used herein, the following definitions shall apply:

 

2.1.                             “Affiliate” means as to any Person, any other Person that directly or indirectly controls, or is under common control with, or is controlled by, such first Person.  As used in this definition, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean the possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise).

 

2.2.                             “Associated Funds” means, with respect to any Person, any funds managed by such Person or under common management with such Person.

 

2.3.                             “Award” means a grant of Common Stock, Deferred Stock, Restricted Stock, Restricted Stock Units, Options or SARs under the Plan.

 

2.4.                             “Award Agreement” means the written agreement, instrument or document evidencing an Award, including any such item in an electronic medium.

 

2.5.                             “Bankruptcy Code” means the Bankruptcy Reform Act of 1978, as amended and codified in title 11 of the United States Code, 11 U.S.C. §§ 101-1532, as in effect on the date of the Chapter 11 Plan but, with respect to amendments to the Bankruptcy Code subsequent to commencement of the Chapter 11 Cases, only to the extent that such amendments were made expressly applicable to bankruptcy cases which were filed as of the enactment of such amendments.

 

2.6.                             “Bankruptcy Court” means the United States Bankruptcy Court for the District of Delaware or such other court as may have jurisdiction over the Chapter 11 Cases.

 

2.7.                             “Board” means the Board of Directors of the Company.

 

2.8.                             “Change in Control” means, after the Effective Date, any of the following events:

 


 

(a)                                  a “person” (as such term in used in Sections 13(d) and 14(d) of the 1934 Act), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the “beneficial owner” (as defined in Rule 13D-3 under the 1934 Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities (provided that, notwithstanding the foregoing, any such acquisition of 50% or more of the combined voting power of the Company’s then outstanding securities by a Permitted Holder shall not constitute a Change in Control); or

 

(b)                                  during any period of two consecutive years, individuals who at the beginning of such period constitute the Board and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in Section 2.5(a), Section 2.5(c) or Section 2.5(d) hereof) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously approved, cease for any reason to constitute a majority thereof; or

 

(c)                                   the Company merges or consolidates with any other corporation, other than in a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or

 

(d)                                  the complete liquidation of the Company or the sale or other disposition of all or substantially all of the Company’s and its Subsidiaries’ assets determined on a consolidated basis (other than a sale or other disposition to the holders of a majority of the voting power of the Company’s voting securities immediately prior to such sale or other disposition (or to an entity in which such holders own a majority of the voting power, directly or indirectly)).

 

(e)                                   Notwithstanding anything in the Chapter 11 Plan or an Award Agreement to the contrary, (x) if an Award is subject to Section 409A of the Code, no event that, but for this Section, would be a Change in Control as defined in the Chapter 11 Plan or the Award Agreement, as applicable, shall be a Change in Control unless such event is also a “change in control event” as defined in Section 409A of the Code and (y) neither of the following events shall constitute a Change in Control:  (i) a transfer of any note or security, including Common Stock, by a Person that received such note or security under the Chapter 11 Plan or the Purchase Agreement to either an Affiliate of such Person or to another Person that received notes or securities under the Chapter 11 Plan or the Purchase Agreement or (ii) any acquisition by any such Person described in clause (y)(i) or its Affiliates of any note or security, whether in connection with a new issuance by the Company, on the open market, or otherwise.

 

2.9.                             “Chapter 11 Cases” means the joint chapter 11 case of the Company and its Subsidiaries, under Case No. 18-12439 (BLS) in the Bankruptcy Court.

 

2


 

2.10.                      “Chapter 11 Plan” means the First Amended Joint Chapter 11 Plan of Reorganization of the Issuer and its affiliated debtors, dated December 3, 2018, as amended, for the resolution of outstanding claims and interests in the Chapter 11 Cases, as may be modified in accordance with the Bankruptcy Code, including all exhibits, supplements, appendices and schedules.

 

2.11.                      “Code” means the Internal Revenue Code of 1986, as amended, and the Treasury regulations promulgated thereunder.  A reference to any provision of the Code or the Treasury regulations promulgated thereunder shall include reference to any successor provision of the Code or the Treasury regulations.

 

2.12.                      “Committee” means the committee designated by the Board to administer the Plan under Section 4.  The Committee shall have at least two members and each member of the Committee shall be a Non-Employee Director and, upon the listing of the Common Stock on the NASDAQ Stock Market (or other securities exchange), each member of the Committee shall be an “independent director” within the meaning of Rule 5605(a)(2) of the NASDAQ Stock Market Rules (or any equivalent rule of such other exchange).

 

2.13.                      “Common Stock” means the common stock of the Company, par value $0.001 per share, or such other class or kind of shares or other securities resulting from the application of Section 12.

 

2.14.                      “Company” means Egalet Corporation, a Delaware corporation, or any successor corporation.

 

2.15.                      “Company Affiliate” means any entity other than the Subsidiaries in which the Company has a substantial direct or indirect equity interest, as determined by the Board.

 

2.16.                      “Consultant” means an individual who renders services to the Company, a Subsidiary or a Company Affiliate as a consultant, advisor or independent contractor.

 

2.17.                      “Deferral Period” means the period during which the receipt of a Deferred Stock Award under Section 7 will be deferred.

 

2.18.                      “Deferred Stock” means Common Stock to be delivered at the end of a Deferral Period and awarded by the Committee under Section 7.

 

2.19.                      “Effective Date” has the meaning set forth in Section 25.

 

2.20.                      “Employee” means an individual, including an officer or director, who is employed by the Company, a Subsidiary or a Company Affiliate.

 

2.21.                      “Fair Market Value” means the fair market value of Common Stock determined by such methods or procedures as shall be established from time to time by the Committee in good faith and in accordance with applicable law.  If the Common Stock is listed on a national securities exchange following the Effective Date, then the Fair Market Value of Common Stock shall mean, unless otherwise determined by the Committee, on any given date, the closing price of a share of Common Stock on the principal national securities exchange on which the Common Stock is listed

 

3


 

on such date or, if Common Stock was not traded on such date, on the last preceding day on which the Common Stock was traded after the Effective Date.

 

2.22.                      “Incentive Stock Option” means an Option or a portion thereof intended to meet the requirements of an incentive stock option as defined in Section 422 of the Code and designated as an Incentive Stock Option in the applicable Award Agreement.

 

2.23.                      “1934 Act” means the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder.  A reference to any provision of the 1934 Act or rule promulgated under the 1934 Act shall include reference to any successor provision or rule.

 

2.24.                      “Non-Employee Director” means a member of the Board who meets the definition of a “non-employee director” under Rule 16b-3(b)(3) promulgated by the Securities and Exchange Commission under the 1934 Act.

 

2.25.                      “Non-Qualified Stock Option” means an Option or a portion thereof not intended to be an Incentive Stock Option and not designated as an Incentive Stock Option in the applicable Award Agreement.  Any Option (or portion thereof) which is intended to be an Incentive Stock Option but which does not qualify as such shall be a Non-Qualified Stock Option.

 

2.26.                      “Option” means a right to purchase a specified number of shares of Common Stock at a specified price awarded by the Committee under Section 6 of the Plan.

 

2.27.                      “Participant” means any Employee, Consultant or Non-Employee Director who receives an Award.

 

2.28.                      “Performance Goal” means a goal that must be met by the end of a period specified by the Committee, including, without limitation, any one or more of the following as they relate to the Company, its Subsidiaries or Company Affiliates (or any business unit or department thereof): (i) stock price, (ii) market share, (iii) sales, (iv) earnings per share, (v) diluted earnings per share, (vi) diluted net income per share, (vii) return on shareholder equity, (viii) costs, (ix) cash flow, (x) return on total assets, (xi) return on capital or invested capital, (xii) return on net assets, (xiii) operating income, (xiv) net income, (xv) earnings (or net income) before interest, taxes, depreciation and amortization, (xvi) improvements in capital structure, (xvii) gross, operating or other margins, (xviii) budget and expense management, (xix) productivity ratios, (xx) working capital targets, (xxi) enterprise value, (xxii) safety record, (xxiii) completion of acquisitions or business expansion of the Company, its Subsidiaries or Company Affiliates (or any business unit or department thereof) (xxiv) economic value added or other value added measurements, (xxv) expenses targets, (xxvi) operating efficiency, (xxvii) regulatory body approvals for commercialization of products,  (xxviii) implementation or completion of critical projects or related milestones (including, without limitation, milestones such as clinical trial enrollment targets, commencement of phases of clinical trials and completion of phases of clinical trials) or (xxix) partnering or similar transactions, in all cases, whether measured absolutely or relative to an index or peer group.  The Committee shall have discretion to determine the specific targets with respect to each of these categories of Performance Goals.

 

2.29.                      “Person” means an individual, a partnership, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated

 

4


 

organization, investment fund, any other business entity and a governmental entity or any department, agency or political subdivision thereof.

 

2.30.                      “Permitted Holders” means, at any time, each of (i) Iroko Pharmaceuticals Inc., a business company incorporated in the British Virgin Islands (registered number 1732699) and its Affiliates, (ii) CR Group L.P. and its Affiliates and Associated Funds, including, without limitation, CRG Servicing LLC, CRG Partners III L.P., CRG Partners III — Parallel Fund “A” L.P., CRG Partners III (Cayman) L.P.,  CRG Partners III (Cayman) LEV AIV I L.P., CRG Partners III (Cayman) UNLEV AIV I, L.P. and CRG Partners III — Parallel Fund “B” (Cayman) L.P., (iii) CI Investments Inc. and its Affiliates and Associated Funds, (iv) Highbridge Capital Management, LLC, and its Affiliates and Associated Funds, (v) Honeywell Capital Management LLC, and its Affiliates and Associated Funds and (vi) any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision) the members of which include any of the Permitted Holders specified in clauses (i) through (v) above and that, directly or indirectly, hold or acquire beneficial ownership of the Voting Stock of the Issuer (a “Permitted Holder Group”), so long as (1) each member of the Permitted Holder Group has voting rights proportional to the percentage of ownership interests held or acquired by such member and (2) no Person or other “group” (other than Permitted Holders specified in clauses (i) through (v) above) beneficially owns more than 50% on a fully diluted basis of the Voting Stock held by the Permitted Holder Group. Any Person or group whose acquisition of beneficial ownership constitutes a Change of Control in respect of which a Change of Control Offer is made in accordance with the requirements of this Indenture will thereafter, together with its Affiliates and funds (or portions of funds) managed by any of the foregoing or under common management with any of the foregoing, constitute an additional Permitted Holder.

 

2.31.                      “Plan” means the Egalet Corporation Amended and Restated 2019 Stock-Based Incentive Compensation Plan herein set forth, as amended and/or restated from time to time.

 

2.32.                      “Purchase Agreement” means  that certain asset purchase agreement, dated as of October 30, 2018, by and among Egalet Corporation (and one or more of its direct or indirect subsidiaries) and Iroko Pharmaceuticals Inc. (and one or more of its direct or indirect subsidiaries) (including, without limitation, all exhibits, supplements, appendices, and schedules thereto), as may be amended, modified, or supplemented from time to time in accordance with the terms thereof, which agreement was approved by the Bankruptcy Court in the Chapter 11 Cases.

 

2.33.                      “Restricted Stock” means Common Stock awarded by the Committee under Section 8 of the Plan.

 

2.34.                      “Restricted Stock Unit” means the right to a payment in Common Stock or in cash, or in a combination thereof, awarded by the Committee under Section 9 of the Plan.

 

2.35.                      “Restriction Period” means the period during which Restricted Stock awarded under Section 8 of the Plan and Restricted Stock Units awarded under Section 9 of the Plan are subject to forfeiture.

 

2.36.                      “SAR” means a stock appreciation right awarded by the Committee under Section 11 of the Plan.

 

5


 

2.37.                      “Subsidiary” means any corporation (other than the Company), partnership, joint venture or other business entity of which 50% or more of the outstanding voting power is beneficially owned, directly or indirectly, by the Company.

 

2.38.                      “Ten Percent Shareholder” means a person who on any given date owns, either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or a Subsidiary.

 

2.39.                      “Voting Stock” of any Person as of any date means the capital stock of such Person that is at the time entitled to vote in the election of the board of directors of such Person.

 

2.40.                      “Underwater Option” means an Option for which the Fair Market Value of the underlying Common Stock is less than the exercise price of that Option.

 

2.41.                      “Underwater SAR” means a SAR for which the Fair Market Value of the Common Stock relating to such SAR is less than the grant price of that SAR.

 

3.                                       Eligibility

 

Any Employee, Consultant or Non-Employee Director is eligible to receive an Award.

 

4.                                       Administration and Implementation of Plan; No Repricings

 

4.1.                             The Plan shall be administered by the Committee.  Any action of the Committee in administering the Plan shall be final, conclusive and binding on all persons, including the Company, its Subsidiaries and Company Affiliates, their Employees, Consultants and directors, Participants, persons claiming rights from or through Participants and stockholders of the Company.  No member of the Committee shall be personally liable for any action, determination, or interpretation taken or made in good faith by the Committee with respect to the Plan or any Awards granted hereunder, and all members of the Committee shall be fully indemnified and protected by the Company in respect of any such action, determination or interpretation.

 

4.2.                             Subject to the provisions of the Plan, the Committee shall have full and final authority in its discretion (a) to select the Employees, Consultants and Non-Employee Directors who will receive Awards pursuant to the Plan, (b) to determine the type or types of Awards to be granted to each Participant, (c) to determine the number of shares of Common Stock to which an Award will relate, the terms and conditions of any Award granted under the Plan (including, but not limited to, restrictions as to vesting, transferability or forfeiture, exercisability or settlement of an Award and waivers or accelerations thereof, and waivers of or modifications to performance conditions relating to an Award, based in each case on such considerations as the Committee shall determine) and all other matters to be determined in connection with an Award; (d) to determine whether, to what extent, and under what circumstances an Award may be canceled, forfeited, or surrendered; (e) to determine whether Performance Goals to which the settlement of an Award is subject are satisfied; (f) to correct any defect or supply any omission or reconcile any inconsistency in the Plan, and to adopt, amend and rescind such rules and regulations as, in its opinion, may be advisable in the administration of the Plan; and (g) to construe and interpret the Plan and to make all other determinations as it may deem necessary or advisable for the administration of the Plan.

 

6


 

4.3.                             The Committee’s powers shall also include responsibility to determine the effect, if any, of a Change in Control of the Company upon outstanding Awards.  Upon a Change in Control, the Committee may, at its discretion, (i) fully vest any or all Awards made under the Plan, (ii) determine whether all applicable Performance Goals have been achieved and the applicable level of performance, (iii) cancel any outstanding Option or SAR in exchange for a payment of an amount (including zero) equal to the difference between the then Fair Market Value of the shares of Common Stock underlying the portion of such Award being cancelled less the aggregate option or base price of the portion of such Award being cancelled (if the per share option or base price of such award equals or exceeds the Fair Market Value of one share of Common Stock, such Award may be cancelled with no payment due to the holder thereof), (iv) after having given the Participant a reasonable chance to exercise any vested outstanding Options or SARs, terminate any or all of the Participant’s unexercised Options or SARs, (v) where the Company is not the surviving corporation, cause the surviving corporation to assume all outstanding Awards or replace all outstanding Awards with comparable awards or (vi) take such other action as the Committee shall determine to be appropriate.

 

4.4.                             The Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter, such terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including terms requiring forfeiture of Awards in the event of the Participant’s termination of employment or service with the Company or any Subsidiary or Company Affiliate; provided, however, that the Committee shall retain full power to accelerate or waive any such term or condition as it may have previously imposed, including, without limitation, any minimum vesting period.  All Awards shall be evidenced by an Award Agreement.  The right of a Participant to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such Performance Goals as may be specified by the Committee.

 

4.5.                             To the extent permitted by applicable law, the Committee may delegate some or all of its authority with respect to the Plan and Awards to any executive officer of the Company or any other person or persons designated by the Committee, in each case, acting individually or as a committee, provided that the Committee may not delegate its authority hereunder to make awards to Employees who are (i) “officers” as defined in Rule 16a-1(f) under the 1934 Act or (ii) officers or other Employees who are delegated authority by the Committee pursuant to this Section.  Any delegation hereunder shall be subject to the restrictions and limits that the Committee specifies at the time of such delegation or thereafter.  The Committee may at any time rescind the authority delegated to any person pursuant to this Section.  Any action undertaken by any such person or persons in accordance with the Committee’s delegation of authority pursuant to this Section shall have the same force and effect as if undertaken directly by the Committee.

 

4.6.                             Notwithstanding anything in the Plan or an Award Agreement to the contrary, no Underwater Option or Underwater SAR may be repriced, replaced or regranted through cancellation, nor may any Underwater Option or Underwater SAR be repurchased for cash, in any case, without the approval of the stockholders of the Company, provided that nothing herein shall prevent the Committee from taking any action provided for in Sections 4.3 and 12.

 

7


 

5.                                       Shares of Stock Subject to the Plan

 

5.1.                             Subject to adjustment as provided in Section 12, the total number of shares of Common Stock available for Awards under the Plan shall be the sum of (x) 1,433,333, which may be issued only to executives of the Company, a Subsidiary or any Company Affiliate, as determined by the Committee (the “Executive Equity Pool”), plus (y) 716,667, which may be issued only to eligible Persons who are not executives of the Company, any Subsidiary or any Company Affiliate, as determined by the Committee (the “Non-Executive Equity Pool,” and together with the Executive Equity Pool, the “Equity Pool”).

 

5.2.                             Subject to adjustment as provided in Section 12, the maximum number of shares of Common Stock available for Awards that are intended to be Incentive Stock Options shall not exceed 2,150,000 (the “ISO Limit”).

 

5.3.                             If any shares subject to an Award are forfeited or such Award otherwise terminates, any shares counted against the number of shares available for issuance pursuant to the Plan with respect to such Award shall, to the extent of any such forfeiture or termination, again be available for Awards under the Plan; provided, however, that (i) if the forfeiture or termination relates to an Award that was granted under the Executive Equity Pool, then the shares covered by such Award that are again available for issuance under the Plan shall be added back only to the Executive Equity Pool, (ii) if the forfeiture or termination relates to an Award that was granted under the Non-Executive Equity Pool, then the shares covered by such Award that are again available for issuance under the Plan shall be added back only to the Non-Executive Equity Pool and (iii) the Committee may adopt procedures for the counting of shares relating to any Award to ensure appropriate counting, avoid double counting, and provide for adjustments in any case in which the number of shares actually distributed differs from the number of shares previously counted in connection with such Award.  SARs and Restricted Stock Units, in each case, to be settled in shares of Common Stock shall be counted in full against the number of shares available for award under the Plan based on the number of shares to which such Awards relate, regardless of the number of shares of Common Stock issued upon settlement of the SAR or Restricted Stock Unit.  If any shares subject to an Award are retained or reacquired by the Company in payment of an exercise price or satisfaction of a withholding or other tax obligation in connection with any Award, such shares shall not be made available for future Awards under the Plan.

 

5.4.                             Any shares issued hereunder may consist, in whole or in part, of authorized and unissued shares or treasury shares.  Any shares issued by the Company through the assumption or substitution of outstanding grants in connection with the acquisition of another entity shall not reduce the maximum number of shares available for delivery under the Plan.

 

6.                                       Common Stock

 

An Award of Common Stock is a grant by the Company of a specified number of shares of Common Stock to the Participant, which shares are not subject to forfeiture except as set forth in Section 20.  Upon the Award of Common Stock, the Committee may direct the number of shares of Common Stock subject to such Award be issued to the Participant, designating the Participant as the registered owner.  The Participant shall have all of the customary rights of a stockholder with respect to the Award of Common Stock, including the right to vote shares of the Common Stock and receive dividends with respect to the Common Stock.

 

8


 

7.                                       Deferred Stock

 

An Award of Deferred Stock is an agreement by the Company to deliver to the Participant a specified number of shares of Common Stock at the end of a specified Deferral Period or Periods.  Such an Award shall be subject to the following terms and conditions:

 

7.1.                             Upon the Award of Deferred Stock, the Committee shall direct that the number of shares subject to such Award be credited to the Participant’s account on the books of the Company but that issuance and delivery of the same shall be deferred until the date or dates provided in the Award Agreement.  Prior to issuance and delivery of the Deferred Stock, the Participant shall have no rights as a stockholder with respect to any shares of Deferred Stock credited to the Participant’s account.

 

7.2.                             During the Deferral Period, no dividend shall be paid with respect to shares covered by a Deferred Stock Award and the Participant shall have no future right to any dividend paid during the Deferral Period.

 

7.3.                             The Deferral Period may consist of one or more installments.  Provided that the Deferred Stock has not been previously forfeited, at the end of the Deferral Period or any installment thereof, the shares of Deferred Stock applicable to such installment, shall be issued and delivered to the Participant (or, where appropriate, the Participant’s legal representative) in accordance with the terms of the Award Agreement.

 

8.                                       Restricted Stock

 

An Award of Restricted Stock is a grant by the Company of a specified number of shares of Common Stock to the Participant, which shares are subject to forfeiture upon the happening of specified events.  Such an Award shall be subject to the following terms and conditions:

 

8.1.                             Upon the Award of Restricted Stock, the Committee may direct the number of shares of Common Stock subject to such Award be issued to the Participant or placed in a restricted stock account (including an electronic account) with the transfer agent and in either case designating the Participant as the registered owner.  The certificate(s), if any, representing such shares shall be physically or electronically legended, as applicable, as to sale, transfer, assignment, pledge or other encumbrances during the Restriction Period and, if issued to the Participant, returned to the Company to be held in escrow during the Restriction Period.  In all cases, the Participant shall sign a stock power endorsed in blank to the Company to be held in escrow during the Restriction Period.

 

8.2.                             During the Restriction Period, the Participant shall have the right to vote shares of Restricted Stock.  During the Restriction Period, no dividend shall be paid with respect to the number of shares covered by a Restricted Stock Award and the Participant shall have no future right to any dividend paid during the Restriction Period.

 

8.3.                             Provided that the Restricted Stock has not been previously forfeited, at the end of the Restriction Period the restrictions imposed under the Award Agreement shall lapse with respect to the number of shares specified thereunder, and the legend, if any, imposed hereunder shall be

 

9


 

removed and such number of shares delivered to the Participant (or, where appropriate, the Participant’s legal representative).

 

9.                                       Restricted Stock Units

 

An Award of Restricted Stock Units is a grant by the Company of the right to receive a payment in Common Stock or in cash, or in a combination thereof, that is equal to the Fair Market Value of a share of Common Stock as of the date of vesting or payment, as set forth in the applicable Award Agreement, which right is subject to forfeiture upon the happening of specified events. Such an Award shall be subject to the following terms and conditions:

 

9.1.                             Any amount payable upon the end of the Restriction Period with respect to a Restricted Stock Unit shall be paid by the Company in shares of Common Stock, in cash or in a combination of shares of Common Stock and cash, as determined by the Committee in its sole discretion and as set forth in the Award Agreement.

 

9.2.                             Provided that the Restricted Stock Units have not been previously forfeited, at the end of the Restriction Period the restrictions imposed under the Award Agreement shall lapse with respect to the number of Restricted Stock Units specified thereunder, and shares of Common Stock or cash with a value equal to the Fair Market Value of the shares of Common Stock underlying such Restricted Stock Units shall be delivered to the Participant (or, where appropriate, the Participant’s legal representative).

 

10.                                Options

 

Options give a Participant the right to purchase a specified number of shares of Common Stock from the Company for a specified time period at a fixed price.  Options may be either Incentive Stock Options or Non-Qualified Stock Options.  The grant of Options shall be subject to the following terms and conditions:

 

10.1.                      Option Price:  The price per share at which Common Stock may be purchased upon exercise of an Option shall be determined by the Committee, but shall be not less than 100% of the Fair Market Value of a share of Common Stock on the date of grant (or 110% of such Fair Market Value in the case of an Incentive Stock Option granted to a Ten Percent Shareholder), unless the Option was granted through the assumption of, or in substitution for, outstanding awards previously granted by an entity acquired by the Company or any Subsidiary or Company Affiliate or with which the Company or any Subsidiary or Company Affiliate combines.

 

10.2.                      Term of Options:  The term of an Option shall in no event be greater than ten years (five years in the case of an Incentive Stock Option granted to a Ten Percent Shareholder).

 

10.3.                      Incentive Stock Options:  Each provision of the Plan and each Award Agreement relating to an Incentive Stock Option shall be construed so that each Incentive Stock Option shall be an incentive stock option as defined in Section 422 of the Code, and any provisions of an Award Agreement that cannot be so construed shall be disregarded.  Incentive Stock Options may not be granted to Employees of Company Affiliates or to Consultants or Non-Employee Directors.

 

10


 

10.4.                      Payment of Option Price:  The option price of the shares of Common Stock received upon the exercise of an Option shall be paid within three days of the date of exercise: (i) in cash, (ii) with the proceeds received from a broker-dealer whom the Participant has authorized to sell all or a portion of the Common Stock covered by the Option, or (iii) with the consent of the Committee, in whole or in part in Common Stock held by the Participant and valued at Fair Market Value on the date of exercise.  Notwithstanding the foregoing, a Participant who is subject to Section 16 of the 1934 Act may direct the Company to withhold Shares otherwise to be delivered upon the exercise of an Option in order to pay the exercise price due on such exercise.  An Option may be exercised only for a whole number of shares of Common Stock.

 

11.                                Stock Appreciation Rights

 

SARs give the Participant the right to receive, upon exercise of the SAR, the excess of (i) the Fair Market Value of one share of Common Stock on the date of exercise over (ii) the grant price of the SAR as determined by the Committee, but which may never be less than 100% of the Fair Market Value of a share of Common Stock on the date of grant.  The grant of SARs shall be subject to the following terms and conditions:

 

11.1.                      The term of a SAR shall in no event be greater than ten years.

 

11.2.                      The Committee shall determine the time or times at which a SAR may be exercised in whole or in part, the method of exercise, the method of settlement, form of consideration payable in settlement, method by which Common Stock will be delivered or deemed to be delivered to Participants, whether or not a SAR shall be in tandem with any other Award, and any other terms and conditions of any SAR.

 

11.3.                      The Committee may provide that a SAR shall be deemed to be exercised at the close of business on the scheduled expiration date of such SAR.

 

12.                                Adjustments upon Changes in Capitalization

 

12.1.                      In order to prevent dilution or enlargement of the rights of Participants under the Plan as a result of any stock dividend, recapitalization, forward stock split or reverse stock split, reorganization, division, merger, consolidation, spin-off, combination, repurchase or share exchange, extraordinary or unusual cash distribution or other similar corporate transaction or event that affects the Common Stock, the Committee shall adjust (i) the number and kind of shares of Common Stock which may thereafter be issued in connection with Awards, (ii) the number and kind of shares of Common Stock issuable in respect of outstanding Awards, (iii) the aggregate number and kind of shares of Common Stock available under the Plan (including under each of the Executive Equity Pool and the Non-Executive Equity Pool), (iv) the ISO Limit and (v) the exercise or grant price relating to any Award.  Any such adjustment shall be made in an equitable manner which reflects the effect of such transaction or event.  It is provided, however, that in the case of any such transaction or event, the Committee may make any additional adjustments to the items in (i) through (v) above which it deems appropriate in the circumstances, or make provision for a cash payment with respect to any outstanding Award; and it is provided, further, that no adjustment shall be made under this Section that would cause the Plan to violate Section 422 of the Code with respect to Incentive Stock Options.

 

11


 

12.2.                      In addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards, including any Performance Goals, in recognition of unusual or nonrecurring events (including, without limitation, events described in Section 12.1) affecting the Company, any Subsidiary or Company Affiliate, or in response to changes in applicable laws, regulations, or accounting principles.

 

13.                                Termination and Amendment

 

13.1.                      The Board may amend, alter, suspend, discontinue, or terminate the Plan without the consent of the Company’s stockholders or Participants, except that any such amendment, alteration, suspension, discontinuation, or termination shall be subject to the approval of the Company’s stockholders if (i) such action results in the repricing, replacement or repurchase of any Option, SAR  or other Award or (ii) such stockholder approval is required by any federal or state law or regulation or the rules of any stock exchange or automated quotation system on which the Common Stock may then be listed or quoted, in each case, except as provided in Section 12.1; provided, however, that without the consent of an affected Participant, no amendment, alteration, suspension, discontinuation, or termination of the Plan may materially and adversely affect the rights of such Participant under any Award theretofore granted and any Award Agreement relating thereto, except as the Committee determines in its sole discretion to be necessary or advisable to comply with Section 409A of the Code or an exemption therefrom or except as otherwise provided in Section 4.3.  The Committee may waive any conditions or rights under, or amend, alter, suspend, discontinue, or terminate, any Award theretofore granted and any Award Agreement relating thereto; provided, however, that without the consent of an affected Participant, no such amendment, alteration, suspension, discontinuation, or termination of any Award may materially and adversely affect the rights of such Participant under such Award, except as the Committee determines in its sole discretion to be necessary or advisable to comply with Section 409A of the Code or an exemption therefrom or except as otherwise provided in Section 4.3.

 

13.2.                      The foregoing notwithstanding, any Performance Goal or other performance condition specified in connection with an Award shall not be deemed a fixed contractual term, but shall remain subject to adjustment by the Committee, in its discretion at any time in view of the Committee’s assessment of the Company’s strategy, performance of comparable companies, and other circumstances.

 

14.                                No Right to Award, Employment or Service

 

Neither the Plan nor any Award nor any action taken hereunder shall be construed as giving any Employee, Consultant or Non-Employee Director any right to be retained in the employ or service of the Company, any Subsidiary or Company Affiliate.  For purposes of the Plan, transfer of employment or service between the Company and its Subsidiaries and Company Affiliates shall not be deemed a termination of employment or service, except as may be necessary or advisable to comply with Section 409A of the Code or an exemption therefrom.

 

15.                                Taxes

 

The Company, any Subsidiary or Company Affiliate is authorized to withhold from any payment relating to an Award under the Plan, including from a distribution of Common Stock or

 

12


 

any payroll or other payment to a Participant, amounts of withholding and other taxes due in connection with any transaction involving an Award, and to take such other action as the Committee may deem advisable to enable the Company, the Subsidiary or Company Affiliate and Participants to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award.  This authority shall include authority to withhold or receive Common Stock or other property and to make cash payments in respect thereof in satisfaction of a Participant’s tax obligations.  Participants who are subject to the reporting requirements of Section 16 of the 1934 Act may elect to pay all or a portion of any withholding taxes due in connection with an Award by directing the Company to withhold shares of Common Stock that would otherwise be received in connection with such Award.

 

16.                                Limits on Transferability; Beneficiaries

 

No Award or other right or interest of a Participant under the Plan shall be pledged, encumbered, or hypothecated to, or in favor of, or subject to any lien, obligation, or liability of such Participant to, any party, other than the Company, any Subsidiary or Company Affiliate, or assigned or transferred by such Participant otherwise than by will or the laws of descent and distribution, and such Awards and rights shall be exercisable during the lifetime of the Participant only by the Participant or his or her guardian or legal representative. Notwithstanding the foregoing, the Committee may, in its discretion, provide that Awards or other rights or interests of a Participant granted pursuant to the Plan (other than an Incentive Stock Option) be transferable, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only partners.  The Committee may attach to such transferability feature such terms and conditions as it deems advisable.  In addition, a Participant may, in the manner established by the Committee, designate a beneficiary (which may be a person or a trust) to exercise the rights of the Participant, and to receive any distribution, with respect to any Award upon the death of the Participant.  A beneficiary, guardian, legal representative or other person claiming any rights under the Plan from or through any Participant shall be subject to all terms and conditions of the Plan and any Award Agreement applicable to such Participant, except as otherwise determined by the Committee, and to any additional restrictions deemed necessary or appropriate by the Committee.

 

17.                                No Rights to Awards; No Stockholder Rights

 

No Participant shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of Participants.  No Award shall confer on any Participant any of the rights of a stockholder of the Company unless and until Common Stock is duly issued or transferred to the Participant in accordance with the terms of the Award.

 

18.                                Foreign Nationals.

 

Without amending the Plan, Awards may be granted to Employees, Consultants and Non-Employee Directors who are foreign nationals or are employed or providing services outside the United States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the purpose of the Plan.  Moreover, the Committee may approve such supplements to, or amendments, restatements

 

13


 

or alternative versions of, the Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of the Plan as in effect for any other purpose.

 

19.                                Securities Law Requirements

 

19.1.                      No Award granted hereunder shall be exercisable or settled if the Company shall at any time determine that (a) the listing upon any securities exchange, or the registration or qualification under any state or federal law of any Common Stock otherwise deliverable upon such exercise or settlement, or (b) the consent or approval of any regulatory body or the satisfaction of withholding tax or other withholding liabilities, is necessary or appropriate in connection with such exercise or settlement.  In any of the events referred to in clause (a) or clause (b) above, the exercisability and settlement of such Awards shall be suspended and shall not be effective unless and until such withholding, listing, registration, qualifications or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole discretion, notwithstanding any termination of any Award or any portion of any Award during the period when exercisability or settlement has been suspended.

 

19.2.                      The Committee may require, as a condition to the right to exercise, or receive shares of Common Stock in respect of, any Award that the Company receive from the Participant, at the time any such Award is exercised, vests, settled or any applicable restrictions lapse, representations, warranties and agreements to the effect that the shares are being purchased or acquired by the Participant for investment only and without any present intention to sell or otherwise distribute such shares and that the Participant will not dispose of such shares in transactions which, in the opinion of counsel to the Company, would violate the registration provisions of the Securities Act of 1933, as then amended, and the rules and regulations thereunder.  The certificates issued to evidence such shares shall bear appropriate legends summarizing such restrictions on the disposition thereof.

 

20.                                Recoupment

 

Any Award granted pursuant to the Plan shall be subject to mandatory repayment by the Participant to the Company pursuant to the terms of any Company “clawback” or recoupment policy directly applicable to the Plan and (i) set forth in the Participant’s Award Agreement or (ii) required by law, or the rules of any national securities exchange on which the Common Stock is listed.

 

21.                                Termination

 

Unless the Plan previously shall have been terminated by action of the Board, the Plan shall terminate on the 10-year anniversary of the Effective Date, and no Awards under the Plan shall thereafter be granted.  Notwithstanding the termination of the Plan, the terms of the Plan shall remain in effect with respect to any Awards outstanding at the time of such termination.

 

22.                                Fractional Shares

 

The Company will not be required to issue any fractional shares of Common Stock pursuant to the Plan.  The Committee may provide for the elimination of fractions and for the settlement of fractions in cash.

 

14


 

23.                                Governing Law

 

To the extent that Federal laws do not otherwise control, the validity and construction of the Plan and any Award Agreement entered into thereunder shall be construed and enforced in accordance with the laws of the State of Delaware, but without giving effect to the choice of law principles thereof.

 

24.                                Code Section 409A.

 

The Plan and all Awards are intended to comply with, or be exempt from, Code Section 409A and all regulations, guidance, compliance programs and other interpretative authority thereunder, and shall be interpreted in a manner consistent therewith.  In the event that a Participant is a “specified employee” within the meaning of Code Section 409A, and a payment or benefit provided for under the Plan would be subject to additional tax under Code Section 409A if such payment or benefit is paid within six (6) months after such Participant’s separation from service (within the meaning of Code Section 409A), then such payment or benefit shall not be paid (or commence) during the six (6) month period immediately following such Participant’s separation from service except as provided in the immediately following sentence. In such an event, any payments or benefits that would otherwise have been made or provided during such six (6) month period and which would have incurred such additional tax under Code Section 409A shall instead be paid to the Participant in a lump-sum, without interest, on the earlier of (i) the first business day of the seventh month following the month in which such Participant’s separation from service occurs or (ii) the tenth business day following such Participant’s death (but not earlier than if such delay had not applied). A Participant’s right to receive any installment payments under an Award Agreement, including without limitation as the result of any deferral of an Award in accordance with Code Section 409A, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under Code Section 409A.  Notwithstanding anything contained in the Plan or in an Award Agreement to the contrary, neither the Company, any member of the Committee (in their capacity as such), any Subsidiary nor any Company Affiliate shall have any liability or obligation to any Participant or any other Person for taxes, interest, penalties or fines (including without limitation any of the foregoing resulting from the failure of any Award granted hereunder to comply with, or be exempt from, Code Section 409A).  Any Award that is to be settled or paid upon a termination of employment or service and that constitutes “non-qualified deferred compensation” under Code Section 409A shall not be paid or settled unless such termination of employment or service constitutes a “separation from service” within the meaning of Code Section 409A.

 

25.                                Effective Date

 

The Plan shall be effective as of the date it is approved by the Board (the “ Effective Date ”).

 

[End of Plan.]

 

15


Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement (Form S-8) pertaining to the Amended and Restated 2019 Stock-Based Compensation Plan of Egalet Corporation of our report dated March 29, 2019, with respect to the consolidated financial statements of Egalet Corporation included in its Annual Report (Form 10-K) for the year ended December 31, 2018, filed with the Securities and Exchange Commission.

 

/s/ ERNST & YOUNG LLP

 

Philadelphia, PA

March 29, 2019